# Kiora Pharmaceuticals (KPRX) — News

KPRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/kprx/news

## Recent headlines

- [Orora: For SaveGlass, ongoing impacts from US tariffs, accelerated effects of Middle East conflict resulted in adverse price and mix effects in 2H26](https://www.ainvest.com/news/orora-saveglass-ongoing-impacts-tariffs-accelerated-effects-middle-east-conflict-resulted-adverse-price-mix-effects-2h26-2610) — AInvest Wire, Oct 13, 2026
  Orora has reported adverse price and mix effects in the second half of 2026, primarily attributed to ongoing impacts from U.S. tariffs and the accelerated effects of the Middle East conflict. These factors have disrupted supply chains and altered market dynamics, particularly in the glass…
- [Fibra Macquarie technical committee says Fibra MTY offer fair](https://www.ainvest.com/news/fibra-macquarie-technical-committee-fibra-mty-offer-fair-2610) — AInvest Wire, Oct 13, 2026
  Fibra Macquarie’s technical committee has concluded that the offer from Fibra MTY is fair, marking a key step in the ongoing merger process. The proposed transaction, valued at approximately $6.5 billion, would combine two major real estate investment trusts in Mexico, creating one of the country’s…
- [Mohamed Aiman Kamal El Din Mohamed Abdul Khaliq Korra sells 34.2 mln shares in Korra Holding for EGP 205.3 mln - EGX](https://www.ainvest.com/news/mohamed-aiman-kamal-el-din-mohamed-abdul-khaliq-korra-sells-34-2-mln-shares-korra-holding-egp-205-3-mln-egx-2610) — AInvest Wire, Oct 13, 2026
  Mohamed Aiman Kamal El Din Mohamed Abdul Khaliq Korra has sold 34.2 million shares in Korra Holding (KORA) for a total value of EGP 205.3 million, according to recent data from the Egyptian Exchange . The transaction reflects significant activity in the stock, which has seen a recent decline in…
- [Kiora Pharmaceuticals - eligible for double digit royalties on net sales of KIO-301 in South Korea - SEC filing](https://www.ainvest.com/news/kiora-pharmaceuticals-eligible-double-digit-royalties-net-sales-kio-301-south-korea-sec-filing-2608) — AInvest Wire, Aug 19, 2026
- [Kiora Pharmaceuticals - enters exclusive license agreement with CKD effective August 20, 2026 - SEC filing](https://www.ainvest.com/news/kiora-pharmaceuticals-enters-exclusive-license-agreement-ckd-effective-august-20-2026-sec-filing-2608) — AInvest Wire, Aug 19, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).